Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
CONTEXT: The optimal frequency for on-treatment serum T measurement used for dose adjustment after transdermal T gel application is unknown, especially in older men with thinner skin and slower metabolic clearance. OBJECTIVES: The objectives of the study was to determine the variability of postgel application serum T concentrations and assess whether single levels are reflective of average serum T concentrations over 24 hours (Cavg0-24). DESIGN: This was a double-blinded, placebo-controlled randomized trial. SETTING: The study was conducted at five academic centers. PARTICIPANTS: Forty-seven symptomatic men 65 years old or older with an average of two morning T concentration less than 275 ng/dL participated in the study. INTERVENTION(S): Transdermal T or placebo gel was applied for 120 ± 14 days. Monthly dose adjustments were made if necessary to target serum T between 400 and 500 to 800 ng/dL. MAIN OUTCOME MEASURES: Variability of serum T 2 hours after the gel application on two outpatient visits and at multiple time points over 24 hours during the inpatient day was measured. RESULTS: On-treatment T levels varied substantially on the 2 ambulatory days and over 24 hours during the inpatient day. Ambulatory 2-hour postapplication T levels did not correlate significantly with either 2-hour postapplication serum T or Cavg0-24 measured during the inpatient day. Only 22.2% of men receiving T had a Cavg0-24 within the target range of 500-800 ng/dL; 81.5% had a Cavg0-24 within the broader 300-1000 ng/dL range. CONCLUSION: Large within-individual variations in serum T after T gel application render ambulatory 2-hour postapplication T level a poor indicator of average serum T on another day. Our data point out the limitations of dose adjustments based on a single postapplication serum T measurement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Studies, primarily in women close to or after the natural age of menopause, have shown that oral estrogen or combined estrogen/progestogen therapy are very effective in alleviating vasomotor symptoms of hypoestrogenism (hot flushes and night sweats) (151) and improving vaginal atrophy (152), urinary frequency, and dysuria (153).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [151]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 25 · Cited by 39
Metadata
- Authors
- Swerdloff, R. S., Pak, Y., Wang, C., Liu, P. Y., Bhasin, S., Gill, T. M., Matsumoto, A. M., Pahor, M., Surampudi, P., & Snyder, P. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Swerdloff, Ronald S.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-09
- Volume
- 100
- Issue
- 9
- Pages
- 3280-3287
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4570167
- OpenAlex
- W2120319122
- Semantic Scholar
- 1b1a6da6be04e107d5113b03bad4a9e27ebdda7d
- Cited by
- 39
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 5 · 2017: 8 · 2016: 6 · 2015: 1
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (UL1TR000124, 5t32dk007571-25, UL1TR000142, 5p30ag031679-15)
- National Institute on Aging (U01AG030644, K07AG043587, P30-AG031679, P30AG028740, P30AG021342)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK-007571)
- National Center for Research Resources (UL1RR025771)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- transdermal testosterone gel, hypogonadism, older men, dose adjustment, treatment monitoring
- MeSH terms
- Administration, Cutaneous, Aged, Dose-Response Relationship, Drug, Double-Blind Method, Gels, Humans, Hypogonadism, Male, Testosterone, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications. https://app.cochat.ai/papers/10.1210/jc.2015-1542
- The paper
- Swerdloff, R. S., Pak, Y., Wang, C., Liu, P. Y., Bhasin, S., Gill, T. M., Matsumoto, A. M., Pahor, M., Surampudi, P., & Snyder, P. J. (2015). Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2015-1542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.